More articles about: Ovarian Cancer
News Release
U-M researcher receives Cancer Grand Challenges funding to crack the dark proteome of cancer
John Prensner, MD, PhD at University of Michigan Health C.S. Mott Children’s Hospital and research member at the Rogel Cancer Center is part of a research team called ILLUMINE which will receive a Cancer Grand Challenges award.
News Release
Can AI help predict outcomes in ovarian cancer?
International team of researchers awarded $2M grant to apply AI to identify factors tied to long term survival
Health Lab
Study defines key driver of aggressive ovarian cancer
A study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer – and offers a potential pathway for new treatments.
Philanthropy News
A Family’s Cancer Journey and Loss Inspire an Oncology Nursing Excellence Award
Julie was a master gardener who grew up on a fruit farm in southwest Michigan. She also had a family history of cancer, which sadly foreshadowed her own ovarian cancer diagnosis.
Health Lab
Research sheds light on low rates of genetic testing for cancer
Research finds genetic testing for cancer can bring more knowledge to patients and their relatives, but not many people get it done.
Health Lab
Machine learning creates opportunity for new personalized therapies
In cell-line and mouse models of ovarian cancer, researchers developed an interdisciplinary approach to identify metabolic vulnerabilities in certain genes that could be targeted to kill cancer cells.
Health Lab
Changing the treatment of cancer
Breakthroughs in the field of genomics are revolutionizing prevention, diagnosis and care.
Health Lab
Emma’s Michigan Answer: Surviving ovarian cancer and finding a new outlook on life
After surviving ovarian cancer at age 26, Emma found healing through a lifelong passion for art and an adventurousness to try new things she might not have before.
Health Lab
End-of-Life Care Remains Aggressive for People With Ovarian Cancer
Clinical guidelines have encouraged the integration of palliative care, yet medicine lags far behind its goals for ovarian cancer, especially for people of color
Health Lab
A Cure for the Medicine: Helping Patients with Gynecologic Cancer Manage Treatment Side Effects
Estrogen-lowering aromatase inhibitors are frequently prescribed to women with ovarian and uterine cancers. New research sheds light on how side effects impact these patients.
Health Lab
This MicroRNA Might Help Detect, Treat Ovarian Cancer
New ovarian cancer research shows microRNA biomarker miR-181a could hold the key to earlier detection and treatment of the disease.
Health Lab
Ovarian Cancer Survivorship and Living Without a ‘Finish Line’
An ovarian cancer diagnosis gave one 26-year-old patient new perspectives on life and adventure.
Health Lab
What Breast Cancer and Ovarian Cancer Survivors Should Know About New Genetic Testing Recommendations
Michigan Medicine’s Rogel Cancer Center discusses updated recommendations on screening for BRCA1 and BRCA2 genetic mutations.
Health Lab
Innovative Investment Strategy Aids Search for New Cancer Drugs
Three early-stage cancer drug projects receive pilot grants to help them advance from the bench toward the bedside.
Health Lab
Ovarian Cancer Survivor: Early Detection, Attitude Are Crucial
Following doctor’s orders — plus a steady dose of faith and positivity — helped a mother of five overcome a stage 4 diagnosis. Now, she’s working to educate others.